Literature DB >> 2838373

A clinical study of immunoglobulin class specific antibody response following hepatitis A.

A Sato1.   

Abstract

Anti-HAV activity was determined by radioimmunoassay for serum fractions of IgG, IgM, and IgA separated with sucrose gradient centrifugation and immunoglobulin absorption using class-specific anti-immunoglobulin. Anti-HAV following hepatitis A was detected initially in IgM and IgA within one week after onset, and also detected in IgG within the next one week. IgM anti-HAV activity reached its peak level at the 21st-30th day of illness with a mean titer of 16.4 by RIA, and then declined gradually, whereas serum IgM concentration increased and reached the peak earlier, and no correlation was seen between them. IgG anti-HAV activity increased rapidly and it exceeded a RIA titer of 80 in 80 days from onset in 12 of the 18 cases. According to the kinetics of IgM and IgG anti-HAV, four types of antibody response following the disease were observed. However, no correlation between antibody response patterns and clinical findings was seen, therefore less relationship of anti-HAV to the liver cell injury was indicated. Furthermore, it was suggested that some immunological mechanisms controlled the level of antigen-specific antibody activity, which maintained the high level of IgM antibody in case of poor response of IgG antibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838373     DOI: 10.1007/BF02799024

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  38 in total

1.  Propagation of human hepatitis A virus in cell culture in vitro.

Authors:  P J Provost; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

2.  A specific complement-fixation test for human hepatitis a employing CR326 virus antigen. Diagnosis and epidemiology.

Authors:  P J Provost; O L Ittensohn; V M Villarejos; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1975-04

3.  The antibody response following hepatitis A infection.

Authors:  S A Locarnini; A A Ferris; N I Lehmann; I D Gust
Journal:  Intervirology       Date:  1977       Impact factor: 1.763

4.  Hepatitis A and meningoencephalitis.

Authors:  K Bromberg; D N Newhall; G Peter
Journal:  JAMA       Date:  1982-02-12       Impact factor: 56.272

5.  Experimental infection of chimpanzees with hepatitis A virus.

Authors:  J L Dienstag; S M Feinstone; R H Purcell; J H Hoofnagle; L F Barker; W T London; H Popper; J M Peterson; A Z Kapikian
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

6.  Immunoglobulin M anti-hepatitis A virus determination reorienting gradient centrifugation for diagnosis of Acute Hepatitis A.

Authors:  G G Frösner; R Scheid; H Wolf; F Deinhardt
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

7.  Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets.

Authors:  M A Kane; D W Bradley; S M Shrestha; J E Maynard; E H Cook; R P Mishra; D D Joshi
Journal:  JAMA       Date:  1984-12-14       Impact factor: 56.272

8.  Relapsing viral hepatitis type A.

Authors:  I M Jacobson; B J Nath; J L Dienstag
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

9.  Serum immunoglobulin levels in acute A, B, and non-A, non-B hepatitis.

Authors:  H Zhuang; J Kaldor; S A Locarnini; I D Gust
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

10.  Propagation of human hepatitis A virus in conventional cell lines.

Authors:  H Kojima; T Shibayama; A Sato; S Suzuki; F Ichida; C Hamada
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.